TI Image
Capturing Clarity

Collaborating with a reliable imaging clinical research organisation (CRO) extends far beyond receiving mere assurance. These partnerships interlace expertise, operational streamlining and a strategic cost-conscious approach that forms the bedrock upon which pharmaceutical and medical research flourish. The effectiveness of this approach is underscored by the fact that around three-quarters of clinical trials are carried out in partnership with CROs, emphasising the significant dependence sponsors have on these organisations.

Among such distinguished entities, one particularly prominent player is TI Image, a global imaging CRO renowned for its distinct proficiency in overseeing clinical trials spanning a spectrum of stages– from the inception of nascent explorations to advanced phases.

At the core of the organisation’s operational excellence lies a team of seasoned professionals comprising medical image experts, imaging project managers, image analysts and imaging physicists. This ensemble enables it to deliver a comprehensive suite of services, ranging from full-service provisions to selected service options.

“Our web-based system efficiently handles medical images across multiple hospitals for comprehensive clinical trials, guaranteeing timely responses to assessments and consultations,” says Amy Jung Hyun Lee, CEO of TI Image.
The company’s web-based platform, ImageTrial, takes centre stage as the foundation of its offerings. It manages the entire imaging workflow, ushering medical images through a sequential journey from initial upload to final central independent review. The platform streamlines the complex orchestration of medical images, ensuring data accuracy, compliance and swift decisionmaking.

The TI Image process begins with skilled project management, involving the coordination of specialists, radiologists and a site management team. This ensures the smooth and effective execution of clinical trial imaging processes. The imaging protocol compliance team then customises imaging parameters to meet the specific demands of different indications. Adopting this enhanced technique to homogenise imaging practices across multiple clinical trials yields an elevation in consistency and accuracy.

A critical essence of TI Image’s process lies in its imaging charter, a comprehensive plan designed in accordance with FDA guidelines.

The charter delineates the blueprint for image collecting, archiving, specialist and radiologist review, as well as the precise criteria for measuring indicators relevant to each clinical trial. This meticulous framework ensures that the complexity of each clinical trial’s imaging need is comprehensively addressed.

Another crucial aspect of the organisation’s operation is its team of medical advisors. These experts—often radiologists and medical specialists—contribute their profound insights to each clinical trial, ensuring the imaging process aligns seamlessly with the trial’s medical objectives. Extensive training is also provided to site staff and readers, empowering them with the knowledge to adeptly navigate imaging intricacies.

Our web-based system efficiently manages medical images across multiple hospitals for comprehensive clinical trials, guaranteeing timely responses to assessments and consultations

TI Image remains steadfast in its dedication to image quality control, adhering to FDA guidelines and its commitment to precision. Each medical image undergoes rigorous quality assessment to ensure it meets the stringent criteria for review. This quality control not only safeguards clinical trial data’s integrity but also assures sponsors and stakeholders of the result’s accuracy.

Adding to its merits is TI Image’s exceptional agility and responsiveness. The organisation’s prompt response times for assessments and consultations act as a compass, keeping the trajectory of clinical trials steady, with any hurdles promptly addressed, be it image quality concerns or site-specific challenges.

Since its inception, TI Image’s adeptness at merging technology, efficient management and regulatory compliance for a seamless clinical trial experience has enabled it to assist numerous international clients. In one such case, the organisation used the web-based platform to showcase its expertise in managing complex medical imaging for a clinical trial. When faced with unclear images due to artefacts, its swift response ensured prompt rescans, which are crucial in time-sensitive cases like oncology.

The organisation’s significance transcends oncology, extending its expertise to various indication clinical trials, from dermatology, ophthalmology to musculoskeletal fields. This pivotal attribute underscores its versatility, catering to an extensive spectrum of indications and altering the modern medical research landscape.

TI Image’s global reach is fortified by an expansive network of radiologists and specialists spanning Europe, America, Singapore and Korea. These collaborations broaden its depth of expertise across various medical indications, allowing it to traverse a wide spectrum of diagnostic challenges, transcending geographical boundaries in the process.

Due to its commitment to data integrity, exceptional agility and an adept team, TI Image exemplifies the future of clinical trials, where technology and expertise converge to redefine medical progress.